Behandling af respiratorisk syncytialvirus-infektioner hos immunkompromitterede hæmatologiske patienter

Søren Thorsen*, Allan Krückow Hornsleth, Bente Klarlund Pedersen, Carsten Johan Heilmann

*Corresponding author af dette arbejde
2 Citationer (Scopus)

Abstract

Respiratory syncytial virus (RSV) accounts for considerable morbidity among infants and elderly, that are otherwise immunocompetent. Immunocompromised haematological patients - in particular bone marrow transplant (BMT) recipients with leukopenia - are at high risk for severe, usually fatal, RSV-pneumonia. No randomized, placebo-controlled studies of aerosolized ribavirin for BMT patients with RSV-pneumonia have been conducted, or can be anticipated. We summarize existing case reports providing circumstantial evidence in favour of an active diagnostic and early therapeutic approach to these patients.

Bidragets oversatte titelTreatment of respiratory syncytial viral infections in immunocompromised haematological patients
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind162
Udgave nummer35
Sider (fra-til)4644-4647
Antal sider4
ISSN0041-5782
StatusUdgivet - 28 aug. 2000
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Behandling af respiratorisk syncytialvirus-infektioner hos immunkompromitterede hæmatologiske patienter'. Sammen danner de et unikt fingeraftryk.

Citationsformater